Recent advances in metabolomics approaches in identification of anti-inflammatory natural products for development of drugs to treat inflammation-associated disorders

Key Points

• Natural products show significant anti-inflammatory activity, highlighting their potential in drug development.
• Key evidence includes findings from recent metabolomics approaches identifying specific compounds with therapeutic effects.
• Assessment using metabolomics techniques identifies compounds targeting inflammation pathways in various models and systems.
• Supports the need for further exploration and characterization of natural products for treating inflammation-associated disorders.